Chandraprabha Vati: Traditional Uses, Evidence & Safety

TL;DR

Chandraprabha Vati is a classical multi-ingredient tablet, some 37 ingredients including guggulu, shilajatu, triphala, trikatu, and iron pyrites, traditionally for urinary disorders, dysuria, stones, and diabetes. The modern record is mostly preclinical: a mouse UTI study, plus lab antioxidant, antimicrobial, and antibiofilm work. One small open-label study in urinary infection reported benefit. No blinded or placebo-controlled trial exists.

What it is

Chandraprabha Vati (also Chandraprabha Gulika/Vatika) is a classical Ayurvedic tablet formulation for urinary-tract and metabolic disorders. The ingredient list is long: commonly 37 items. Representative entries: camphor, vacha (Acorus calamus), mustaka (Cyperus rotundus), haridra (Curcuma longa), ativisha, daruharidra, pippali and pippali-moola, chitraka, trivrit, danti, tejpatra, tvak, ela, vamshalochana, triphala (haritaki, vibhitaka, amalaki), chavya, vidanga, gajapippali, guduchi, trikatu (shunthi, maricha, pippali), the three salts (saindhav, vida, sauvarchala) plus alkaline preparations. The mineral components are: Swarnamakshika bhasma (calcined iron pyrites), Lauha bhasma (calcined iron), shilajatu, guggulu, and sharkara (sugar) (ingredient listing).

The formula's spine is guggulu and shilajatu. The rest is a digestive-carminative-mineral matrix with diuretic and scraping (lekhana) intent (Always Ayurveda review).

Traditional use

The batch data records Chandraprabha Vati as bitter-pungent (Tikta, Katu rasa), light and sharp (Laghu, Tikshna guna), heating (Ushna virya), with Mutrala (diuretic) and Rasayana prabhava. It pacifies Kapha and Vata. Classical indications include urinary-tract infections, dysuria, urinary calculi, prostatitis, diabetes mellitus, emaciation, indigestion, and general weakness (ingredient listing). The traditional logic: piercing (bhedana), scraping (lekhana), and diuretic (mutrala) actions clear urinary obstruction and metabolic waste (Always Ayurveda review).

Consider the traditional section closed. What follows is the research section, on its own terms.

What modern research says

Mouse UTI study (animal)

In mice with urinary-tract infection, Chandraprabha Vati modulated antimicrobial peptide expression and inflammatory markers in kidney tissue (animal study) (Iranian Journal of Kidney Diseases 2013). That is the most on-indication modern study identified: the traditional target (urinary tract) tested in a living animal.

Laboratory characterization (in-vitro)

An ethanolic extract was profiled for phytochemistry (flavonoids, phenolics, alkaloids, saponins, glycosides), antioxidant activity (DPPH IC₅₀ 37.3 µg/ml), broad-spectrum antimicrobial activity with antibiofilm effects against multidrug-resistant strains, and no cytotoxicity in L929/HEK-293 cell lines at tested concentrations. HR-LCMS identified candidate bioactives (Phytomedicine Plus formulation-validation paper). In-vitro antimicrobial activity is chemistry, not clinical efficacy against human UTI.

Comparative clinical study (human)

A small comparative clinical study at an Ayurvedic college hospital (JAIMS, 2020) evaluated Chandraprabha Vati versus Gudamalaka Yoga. The patients had Pittaja Mutrakruchra, correlated with lower urinary-tract infection. The authors reported both formulations as "very effective" in managing UTI symptoms (Kudari & Parvathy, JAIMS 2020). No sample size or blinding details appear in the abstract. The honest read is that this is a small, open, single-center comparison: supportive of further research, not proof of efficacy.

What the evidence does not support (yet)

No placebo-controlled or blinded trial of Chandraprabha Vati was identified, not for UTI, dysuria, stones, or diabetes. The one small comparative study is open-label and single-center. The mouse and in-vitro data are hypothesis-support only. The "widely prescribed" status is clinical tradition, not clinical evidence.

Safety & contraindications

Mineral components. The formula contains calcined iron pyrites and calcined iron (bhasmas) plus alkaline salts. Properly prepared bhasmas from reputable GMP manufacturers are the standard expectation. Poorly prepared or adulterated products are a real risk with metal-containing formulations. Buy from licensed manufacturers only.

UTI is not a self-treatment zone. Untreated urinary-tract infection can ascend to the kidney (pyelonephritis) and become an emergency. Do not delay antibiotics evaluation in favor of a traditional tablet.

General. Heating and pungent in classical terms. The formula contains strong purgatives (trivrit, danti) in the mix, so GI upset is plausible. No pregnancy, lactation, or drug-interaction studies were identified. Diabetics should note the sharkara (sugar) content. They should not use it to replace glucose-lowering therapy.

FAQs

What is Chandraprabha Vati?

A classical Ayurvedic tablet of ~37 ingredients, herbs plus guggulu, shilajatu, and calcined mineral bhasmas, traditionally used for urinary disorders, dysuria, stones, and metabolic conditions (ingredient listing).

Does it treat urinary-tract infections?

A mouse UTI study showed modulation of kidney antimicrobial peptides and inflammatory markers (Iranian Journal of Kidney Diseases 2013). Separate lab work shows antimicrobial and antibiofilm activity (Phytomedicine Plus). No human trial exists. UTI needs prompt medical evaluation. This is not a substitute.

Is it safe for long-term use?

No long-term safety data exist. The mineral bhasma components make manufacturer quality (GMP, licensed pharmacy) the decisive variable.

Can I use it for diabetes?

Traditional indication includes diabetes mellitus, but no human trial supports glycemic efficacy. Do not replace diabetes medication with it.

Why is there no dosage section in this article?

Our editorial rule is to state doses only with a pharmacopoeial monograph or clinical-trial citation. Commercial labels suggest 1–2 tablets once or twice daily. But that is manufacturer labeling, not a tested or monograph dose, so we do not present it as one.

Sources

The ingredient list (~37 items including Swarnamakshika bhasma, Lauha bhasma, shilajatu, guggulu, triphala, trikatu, three salts) and classical indications (UTI, dysuria, calculi, prostatitis, diabetes, emaciation) are the Dabur product monograph listing (page). The mouse UTI findings (antimicrobial peptides, inflammatory markers in kidneys) are the Iranian Journal of Kidney Diseases 2013 paper (article); the in-vitro antimicrobial/antibiofilm/antioxidant characterization (DPPH IC₅₀ 37.3 µg/ml; no cytotoxicity in L929/HEK-293) is a separate Phytomedicine Plus formulation-validation paper (record). The small comparative clinical study in lower UTI (Chandraprabha Vati vs Gudamalaka Yoga in Pittaja Mutrakruchra; both reported "very effective") is Kudari & Parvathy, J Ayurveda Integr Med Sci 5(03), 2020 (article).

Disclaimer

This article is for educational purposes only and is not medical advice. Chandraprabha Vati contains calcined mineral bhasmas; use only products from licensed, GMP-certified manufacturers under qualified supervision. Urinary-tract infections can become emergencies — seek medical care promptly and do not delay evaluation. Talk to a qualified healthcare practitioner before use, especially if pregnant, breastfeeding, managing diabetes or kidney disease, or taking prescription medicines.